Want to see GOVX full AI Analyst Report?
GOVX Stock Chart & Stats
$0.73
-$0.11(-12.95%)
At close: 4:00 PM EDT
$0.73
-$0.11(-12.95%)
Day’s Range― - ―
52-Week Range$0.64 - $20.00
Previous CloseN/A
Volume423.18K
Average Volume (3M)453.76K
Market Cap
$5.02M
Enterprise Value$2.98
Total Cash (Recent Filing)$3.14M
Total Debt (Recent Filing)$323.14K
Price to Earnings (P/E)―
Beta3.54
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding7,369,243
10 Day Avg. Volume297,748
30 Day Avg. Volume453,756
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.07
Price to Sales (P/S)1.65
P/FCF Ratio-0.19
Enterprise Value/Market Cap<0.01
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$10.00Price Target Upside1269.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Clinical StudiesAdditional data announcements from clinical studies with 04S1 could be positive catalysts through 2025.
Comparative AnalysisDSMB Review Suggests GEO-CM04S1 May Be Superior to mRNA Vaccine.
Vaccine DevelopmentGEO-CM04S1 booster studies to continue, with early clinical studies showing the vaccine induces durable neutralizing antibody and T-cell-based immunity against current and future variants of SARS-CoV-2.
Bears Say
Contract TerminationTermination of the contract will not have a long-term material effect.
Project TerminationGeoVax Labs announced it received written notification from Advanced Technology International directing GeoVax to stop work on all efforts with respect to a Rapid Response Partnership Vehicle project.
GeoVax Labs News
GOVX FAQ
What was Geovax Labs, Inc.’s price range in the past 12 months?
Geovax Labs, Inc. lowest stock price was $0.64 and its highest was $20.00 in the past 12 months.
What is Geovax Labs, Inc.’s market cap?
Geovax Labs, Inc.’s market cap is $5.02M.
When is Geovax Labs, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Geovax Labs, Inc.’s earnings last quarter?
Currently, no data Available
Is Geovax Labs, Inc. overvalued?
According to Wall Street analysts Geovax Labs, Inc.’s price is currently Undervalued.
Does Geovax Labs, Inc. pay dividends?
Geovax Labs, Inc. does not currently pay dividends.
What is Geovax Labs, Inc.’s EPS estimate?
Geovax Labs, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Geovax Labs, Inc. have?
Geovax Labs, Inc. has 7,369,243 shares outstanding.
What happened to Geovax Labs, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Geovax Labs, Inc.?
Currently, no hedge funds are holding shares in GOVX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Geovax Labs, Inc.
GeoVax Labs, Inc. (GOVX) is a biotechnology company focused on the research and development of vaccines and immunotherapies for infectious diseases and certain cancers. The company’s core work centers on developing product candidates using its proprietary vaccine technology platform(s), with a pipeline that has included programs targeting diseases such as HIV and other infectious disease indications.
GOVX Stock 12 Month Forecast
Average Price Target
$10.00
▲(1269.86% Upside)
Technical Analysis
Ownership Overview
2.50% Insiders
0.23% Mutual Funds
3.65% Other Institutional Investors
93.57% Public Companies and
Individual Investors